Implantable Ocular Device Milestone Reached

Genentech Announces First Milestone Payment to Device-Maker ForSight VISION4, Inc. in Development of Sustained Delivery Lucentis South San Francisco, Calif. – January 13, 2012 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced it will make its first milestone payment to ForSight VISION4, Inc. as part of an exclusive license agreement to develop the company’s investigational drug delivery device, designed to provide sustained delivery of Lucentis® (ranibizumab). […]

January 13th, 2012|

Palm Beach Daily News Article

Macula Vision Research Foundation puts focus on research – If there’s one statement that’s bound to attract Palm Beach donors, it’s the label that’s attached to every piece of literature distributed by Macula Vision Research Foundation. “One hundred percent of every dollar donated goes directly to research.” That’s impressive, and that’s because this foundation, dedicated to finding cures for blindness caused by retinal diseases such as macular degeneration, has all its administrative costs totally funded by a family foundation. […]

January 4th, 2012|

Art4Vision Opens New Gallery In Ft. Lauderdale To Benefit MVRF

The gala event, held December 3rd at The Museum of Art Fort Lauderdale, showcased the work of Art Wolfe with all proceeds benefiting Macula Vision Research Foundation.  Special thanks to Dr. Scott Anagnoste and Art4Vision for supporting MVRF's Research programs.

December 21st, 2011|

Curing Blindness

Curing blindness! Macula Vision Research Foundation (MVRF) is proud to share the results of a clinical trial that has restored sight to its participants. One research study at a time, MVRF is curing blindness! This study, solely funded by MVRF, demonstrates the effectiveness of gene therapy in treating Leber’s Congenital Amaurosis (LCA), a form of [...]

July 12th, 2011|

Join Us In Cleveland!

MVRF is hosting a SupportSight Seminar in Cleveland on Saturday, July 23rd, 2011. We hope you can join us! When: 9:00 a.m. – 12:00 p.m. Where: Corporate College East […]

June 27th, 2011|

NIH Study Finds Avastin And Lucentis Are Equally Effective In Treating Age-Related Macular Degeneration

NEI Press Release NATIONAL INSTITUTES OF HEALTH National Eye Institute NEI Multimedia News Release Contact: National Eye Institute (301) 496-5248 neinews@nei.nih.gov For Immediate Release Thursday, April 28, 2011 11:00 am EDT […]

April 28th, 2011|

MVRF’s 10th International Scientific Conference

FOR IMMEDIATE RELEASE: Breakthrough study regarding childhood blindness shared at Macula Vision Research Foundation’s 10th International Scientific Research Conference in NYC, March 24th – 27th Every 18 months, the Macula Vision Research Foundation hosts a conference that brings together industry-leading retinal scientists, clinicians and medical equipment developers. This year, 25 participants were invited to share their work and collaborate with one another in an interactive setting at the Four Seasons Hotel in New York. […]

April 22nd, 2011|

Encapsulated Cell Therapy Research Update

Age-related macular degeneration, or AMD, is a leading cause of vision loss in Americans age 60 and older. It is a disease that causes cells in the macula – the part of the eye that allows us to see in fine detail – to die.  There are two forms of the disorder, wet and dry AMD.  GA is considered the end stage of dry AMD, where central vision is lost. […]

April 21st, 2011|